Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Insulinoma D007340 28 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Knapp M Cardioprotective role of sphingosine-1-phosphate. 2011 J. Physiol. Pharmacol. pmid:22314562
Berdyshev EV et al. Characterization of sphingosine-1-phosphate lyase activity by electrospray ionization-liquid chromatography/tandem mass spectrometry quantitation of (2E)-hexadecenal. 2011 Anal. Biochem. pmid:20804717
Kikuta J et al. [Encounter of cancer cells with bone. In vivo imaging of osteoclasts and their precursors in intact bone tissues]. 2011 Clin Calcium pmid:21358058
Mair N et al. Genetic evidence for involvement of neuronally expressed S1P₁ receptor in nociceptor sensitization and inflammatory pain. 2011 PLoS ONE pmid:21359147
Ishii T et al. The role of sphingosine 1-phosphate in migration of osteoclast precursors; an application of intravital two-photon microscopy. 2011 Mol. Cells pmid:21360199
Antel J and Hohlfeld R Modulation of sphingosine 1-phosphate signaling in neurologic disease. 2011 Neurology pmid:21360856
Hagen N et al. Sphingosine-1-phosphate links glycosphingolipid metabolism to neurodegeneration via a calpain-mediated mechanism. 2011 Cell Death Differ. pmid:21331079
Meng H et al. Loss of sphingosine kinase 1/S1P signaling impairs cell growth and survival of neurons and progenitor cells in the developing sensory ganglia. 2011 PLoS ONE pmid:22096531
Yuan L et al. [The study on protective effect of sphingosine-1-phosphate in cardiomyocytes]. 2011 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:22097726
Ling B et al. Sphingosine-1-phosphate: a potential therapeutic agent against human breast cancer. 2011 Invest New Drugs pmid:20041340
Lépine S et al. Autophagy induced by deficiency of sphingosine-1-phosphate phosphohydrolase 1 is switched to apoptosis by calpain-mediated autophagy-related gene 5 (Atg5) cleavage. 2011 J. Biol. Chem. pmid:22052905
Jiang Z et al. Metabonomic study on women of reproductive age treated with nutritional intervention: screening potential biomarkers related to neural tube defects occurrence. 2011 Biomed. Chromatogr. pmid:20812204
Durafourt BA et al. Differential responses of human microglia and blood-derived myeloid cells to FTY720. 2011 J. Neuroimmunol. pmid:20826007
Fox TE et al. Circulating sphingolipid biomarkers in models of type 1 diabetes. 2011 J. Lipid Res. pmid:21068007
Wang L et al. FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl. 2011 Eur. Respir. J. pmid:21071472
Siow DL et al. Sphingosine kinase localization in the control of sphingolipid metabolism. 2011 Adv. Enzyme Regul. pmid:21075134
Bieberich E There is more to a lipid than just being a fat: sphingolipid-guided differentiation of oligodendroglial lineage from embryonic stem cells. 2011 Neurochem. Res. pmid:21136155
Yu Y and Qin SC [An active lipid signaling molecule: sphingosine-1-phosphate and its biological characteristics]. 2011 Sheng Li Ke Xue Jin Zhan pmid:21770269
Tanfin Z et al. ATP-binding cassette ABCC1 is involved in the release of sphingosine 1-phosphate from rat uterine leiomyoma ELT3 cells and late pregnant rat myometrium. 2011 Cell. Signal. pmid:21803151
Gault CR and Obeid LM Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy. 2011 Crit. Rev. Biochem. Mol. Biol. pmid:21787121
Qadri SM et al. Sphingosine but not sphingosine-1-phosphate stimulates suicidal erythrocyte death. 2011 Cell. Physiol. Biochem. pmid:21865742
Kharel Y et al. Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate. 2011 Biochem. J. pmid:21848514
García-Sáinz JA et al. Mechanisms involved in α1B-adrenoceptor desensitization. 2011 IUBMB Life pmid:21815242
Yang Y and Uhlig S The role of sphingolipids in respiratory disease. 2011 Ther Adv Respir Dis pmid:21900155
Edmonds Y et al. Development of small-molecule inhibitors of sphingosine-1-phosphate signaling. 2011 Pharmacol. Ther. pmid:21906625
Baranowski M and Górski J Heart sphingolipids in health and disease. 2011 Adv. Exp. Med. Biol. pmid:21910081
Hammad SM Blood sphingolipids in homeostasis and pathobiology. 2011 Adv. Exp. Med. Biol. pmid:21910082
Cuvillier O and Ader I Hypoxia-inducible factors and sphingosine 1-phosphate signaling. 2011 Anticancer Agents Med Chem pmid:21707486
Bedia C et al. Regulation of autophagy by sphingolipids. 2011 Anticancer Agents Med Chem pmid:21707487
Weigert A et al. S1P regulation of macrophage functions in the context of cancer. 2011 Anticancer Agents Med Chem pmid:21707489
Watters RJ et al. Targeting sphingosine-1-phosphate receptors in cancer. 2011 Anticancer Agents Med Chem pmid:21707490
Stevenson CE et al. Targeting sphingosine-1-phosphate in hematologic malignancies. 2011 Anticancer Agents Med Chem pmid:21707492
Bourquin F et al. PLP-dependent enzymes as entry and exit gates of sphingolipid metabolism. 2011 Protein Sci. pmid:21710479
Mathew B et al. Role of sphingolipids in murine radiation-induced lung injury: protection by sphingosine 1-phosphate analogs. 2011 FASEB J. pmid:21712494
Olivera A and Rivera J An emerging role for the lipid mediator sphingosine-1-phosphate in mast cell effector function and allergic disease. 2011 Adv. Exp. Med. Biol. pmid:21713655
Vessey DA et al. P2X7 receptor agonists pre- and postcondition the heart against ischemia-reperfusion injury by opening pannexin-1/P2X₇ channels. 2011 Am. J. Physiol. Heart Circ. Physiol. pmid:21685263
Varo-Sánchez GM et al. [Pharmacological targets in multiple sclerosis]. 2011 Rev Neurol pmid:21678322
Alden KP et al. Sphingolipid long chain base phosphates can regulate apoptotic-like programmed cell death in plants. 2011 Biochem. Biophys. Res. Commun. pmid:21683064
Walzer T and Vivier E G-protein-coupled receptors in control of natural killer cell migration. 2011 Trends Immunol. pmid:21664184
Sánchez BA et al. Targeted analysis of sphingoid precursors in human biofluids by solid-phase extraction with in situ derivatization prior to μ-LC-LIF determination. 2011 Anal Bioanal Chem pmid:21394454
Dickson MA et al. A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors. 2011 Clin. Cancer Res. pmid:21257722
Kennedy AJ et al. Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells. 2011 J. Med. Chem. pmid:21495716
Samadi N et al. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance. 2011 Biochimie pmid:20709140
Soliven B et al. The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators. 2011 Neurology pmid:21339490
Brecht K et al. Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E2. 2011 FASEB J. pmid:21450910
Benamer N et al. Electrophysiological and functional effects of sphingosine-1-phosphate in mouse ventricular fibroblasts. 2011 Biochem. Biophys. Res. Commun. pmid:21420933
Ocaña-Morgner C et al. Sphingosine 1-phosphate-induced motility and endocytosis of dendritic cells is regulated by SWAP-70 through RhoA. 2011 J. Immunol. pmid:21421853
Kato K et al. Regulation by heat shock protein 27 of osteocalcin synthesis in osteoblasts. 2011 Endocrinology pmid:21427224
López-Juárez A et al. Expression of LPP3 in Bergmann glia is required for proper cerebellar sphingosine-1-phosphate metabolism/signaling and development. 2011 Glia pmid:21319224
Yonamine I et al. Sphingosine kinases and their metabolites modulate endolysosomal trafficking in photoreceptors. 2011 J. Cell Biol. pmid:21321100
Lamana A et al. CD69 modulates sphingosine-1-phosphate-induced migration of skin dendritic cells. 2011 J. Invest. Dermatol. pmid:21412255
Yogi A et al. Sphingosine-1-phosphate-induced inflammation involves receptor tyrosine kinase transactivation in vascular cells: upregulation in hypertension. 2011 Hypertension pmid:21383307
Zhu Q et al. A novel lipid natriuretic factor in the renal medulla: sphingosine-1-phosphate. 2011 Am. J. Physiol. Renal Physiol. pmid:21478479
Takasugi N et al. BACE1 activity is modulated by cell-associated sphingosine-1-phosphate. 2011 J. Neurosci. pmid:21543615
Jackson EK Role of sphingosine-1-phosphate in the renal medulla. 2011 Am. J. Physiol. Renal Physiol. pmid:21511695
Greenspon J et al. Sphingosine-1-phosphate regulates the expression of adherens junction protein E-cadherin and enhances intestinal epithelial cell barrier function. 2011 Dig. Dis. Sci. pmid:20936358
Lan T et al. Simultaneous determination of sphingosine and sphingosine 1-phosphate in biological samples by liquid chromatography-tandem mass spectrometry. 2011 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:21292568
McQuiston T et al. Role of sphingosine-1-phosphate (S1P) and S1P receptor 2 in the phagocytosis of Cryptococcus neoformans by alveolar macrophages. 2011 Microbiology (Reading, Engl.) pmid:21292747
Highkin MK et al. High-throughput screening assay for sphingosine kinase inhibitors in whole blood using RapidFire® mass spectrometry. 2011 J Biomol Screen pmid:21297110
Bolli MH et al. Synthetic sphingosine 1-phosphate receptor modulators--opportunities and potential pitfalls. 2011 Curr Top Med Chem pmid:21261590
Hopson KP et al. S1P activates store-operated calcium entry via receptor- and non-receptor-mediated pathways in vascular smooth muscle cells. 2011 Am. J. Physiol., Cell Physiol. pmid:21270296
Ulrych T et al. Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation. 2011 J. Thromb. Haemost. pmid:21251196
Cahalan SM et al. Actions of a picomolar short-acting S1P₁ agonist in S1P₁-eGFP knock-in mice. 2011 Nat. Chem. Biol. pmid:21445057
Sassoli C et al. Effects of S1P on skeletal muscle repair/regeneration during eccentric contraction. 2011 J. Cell. Mol. Med. pmid:21199328
Jang S et al. Modulation of sphingosine 1-phosphate and tyrosine hydroxylase in the stress-induced anxiety. 2011 Neurochem. Res. pmid:21076868
Hisano Y et al. The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720. 2011 J. Biol. Chem. pmid:21084291
Bäumer W et al. Decreased concentration and enhanced metabolism of sphingosine-1-phosphate in lesional skin of dogs with atopic dermatitis: disturbed sphingosine-1-phosphate homeostasis in atopic dermatitis. 2011 J. Invest. Dermatol. pmid:20811395
Majeed Y et al. Stereo-selective inhibition of transient receptor potential TRPC5 cation channels by neuroactive steroids. 2011 Br. J. Pharmacol. pmid:21108630
Lan T et al. Sphingosine kinase-1 pathway mediates high glucose-induced fibronectin expression in glomerular mesangial cells. 2011 Mol. Endocrinol. pmid:21998146
Kang H et al. Fluid shear stress and sphingosine 1-phosphate activate calpain to promote membrane type 1 matrix metalloproteinase (MT1-MMP) membrane translocation and endothelial invasion into three-dimensional collagen matrices. 2011 J. Biol. Chem. pmid:22002053
Gomez L et al. A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection. 2011 Basic Res. Cardiol. pmid:22002221
Yester JW et al. Extracellular and intracellular sphingosine-1-phosphate in cancer. 2011 Cancer Metastasis Rev. pmid:22002715
Pyne S et al. Sphingosine kinase inhibitors and cancer: seeking the golden sword of Hercules. 2011 Cancer Res. pmid:21940750
McGuire PG et al. Pericyte-derived sphingosine 1-phosphate induces the expression of adhesion proteins and modulates the retinal endothelial cell barrier. 2011 Arterioscler. Thromb. Vasc. Biol. pmid:21940944
Karuna R et al. Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism. 2011 Atherosclerosis pmid:21944699
Arnon TI et al. GRK2-dependent S1PR1 desensitization is required for lymphocytes to overcome their attraction to blood. 2011 Science pmid:21960637
Serebrov VIu et al. [Activity of the sphingomyelin cycle enzymes and concentration of products of sphingomyelin degradation in the rat liver in the course of acute toxic hepatitis]. 2010 Mar-Apr Biomed Khim pmid:21341516
Agudo-López A et al. Involvement of mitochondria on neuroprotective effect of sphingosine-1-phosphate in cell death in an in vitro model of brain ischemia. 2010 Neurosci. Lett. pmid:20045720
Nayak D et al. Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia. 2010 Neuroscience pmid:20036321
Danieli-Betto D et al. Sphingosine 1-phosphate signaling is involved in skeletal muscle regeneration. 2010 Am. J. Physiol., Cell Physiol. pmid:20042733
Hoofnagle AN et al. HDL lipids and insulin resistance. 2010 Curr. Diab. Rep. pmid:20425071
De Luca T et al. Reciprocal relationship between cytosolic NADH and ENOX2 inhibition triggers sphingolipid-induced apoptosis in HeLa cells. 2010 J. Cell. Biochem. pmid:20518072
Francis-Goforth KN et al. Normalization of diabetic wound healing. 2010 Surgery pmid:19703697
Ratner M Novartis eyes oral MS drug as potential blockbuster. 2010 Nat. Biotechnol. pmid:21057464
Ponnusamy S et al. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. 2010 Future Oncol pmid:21062159
Chao HH et al. L-Carnitine attenuates angiotensin II-induced proliferation of cardiac fibroblasts: role of NADPH oxidase inhibition and decreased sphingosine-1-phosphate generation. 2010 J. Nutr. Biochem. pmid:19447019
Müller R et al. Expression of sphingosine-1-phosphate receptors and lysophosphatidic acid receptors on cultured and xenografted human colon, breast, melanoma, and lung tumor cells. 2010 Tumour Biol. pmid:20480410
Dubin AE et al. Diversity of lysophosphatidic acid receptor-mediated intracellular calcium signaling in early cortical neurogenesis. 2010 J. Neurosci. pmid:20505096
Rolin J et al. FTY720 and SEW2871 reverse the inhibitory effect of S1P on natural killer cell mediated lysis of K562 tumor cells and dendritic cells but not on cytokine release. 2010 Cancer Immunol. Immunother. pmid:19823820
Suhaiman L et al. Sphingosine 1-phosphate and sphingosine kinase are involved in a novel signaling pathway leading to acrosomal exocytosis. 2010 J. Biol. Chem. pmid:20236935
Lee CW et al. Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis. 2010 Arch. Pharm. Res. pmid:21052934
Martin R Multiple sclerosis: closing in on an oral treatment. 2010 Nature pmid:20237554
Di A et al. A novel function of sphingosine kinase 1 suppression of JNK activity in preventing inflammation and injury. 2010 J. Biol. Chem. pmid:20299461
Cutignano A et al. UPLC-MS/MS method for analysis of sphingosine 1-phosphate in biological samples. 2010 Prostaglandins Other Lipid Mediat. pmid:20601074
Ohno T et al. The prediction of human response to ONO-4641, a sphingosine 1-phosphate receptor modulator, from preclinical data based on pharmacokinetic-pharmacodynamic modeling. 2010 Biopharm Drug Dispos pmid:20623701
Adamson RH et al. Sphingosine-1-phosphate modulation of basal permeability and acute inflammatory responses in rat venular microvessels. 2010 Cardiovasc. Res. pmid:20542878
de Souza JA et al. Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I. 2010 J. Cell. Mol. Med. pmid:19243471
Chiba Y et al. Downregulation of sphingosine-1-phosphate receptors in bronchial smooth muscle of mouse experimental asthma. 2010 Pharmacol. Res. pmid:20554039
Murohara T Printing a tissue: a new engineering strategy for cardiovascular regeneration. 2010 Arterioscler. Thromb. Vasc. Biol. pmid:20554948
Pyne NJ and Pyne S Sphingosine 1-phosphate and cancer. 2010 Nat. Rev. Cancer pmid:20555359